0
Sign In  | Subscribe
16 September 2003, Vol 139, No. 6>
Summaries for Patients | 16 September 2003

Polycythemia Vera and Essential Thrombocythemia in a General Population FREE

[+] Article and Author Information

The summary below is from the full report titled “The Rate of Progression to Polycythemia Vera or Essential Thrombocythemia in Patients with Erythrocytosis or Thrombocytosis.” It is in the 16 September 2003 issue of Annals of Internal Medicine (volume 139, pages 470-475). The authors are M. Ruggeri, A. Tosetto, M. Frezzato, and F. Rodeghiero.


Ann Intern Med. 2003;139(6):I-32. doi:10.7326/0003-4819-139-6-200309160-00002
Text Size: A A A

What is the problem and what is known about it so far?

Erythrocytosis is a condition in which the number of red blood cells, which carry oxygen, is higher than normal. Thrombocytosis is a condition in which the number of platelets, which are the cells that help blood to clot, is higher than normal. Erythrocytosis and thrombocytosis can be the result of another disease process or diseases called polycythemia vera and essential thrombocythemia. Polycythemia vera and essential thrombocythemia may be associated with such problems as blood clots, bleeding, or serious bone marrow diseases, including some types of leukemia. However, many people with polycythemia vera and essential thrombocythemia never develop problems, and there is uncertainty about the best way to treat these diseases. Studies that have used information from hospital discharge records or cancer registries suggest that polycythemia vera and essential thrombocythemia are rare, occurring in only 1 to 5 of every million people. However, no studies have examined the frequency of these conditions in the general population.

Why did the researchers do this particular study?

To estimate the frequency of polycythemia vera and essential thrombocythemia in a general population.

Who was studied?

10 000 adult residents of Vicenza, Italy, who were participating in a large study of cardiovascular disease.

How was the study done?

In all of the people in the study, a blood count was done at the start of the study and again if results from the first test were abnormal. Patients whose second test confirmed high red cell (erythrocytosis) or platelet (thrombocytosis) counts had further testing to see whether they had polycythemia vera or essential thrombocythemia. The researchers followed everyone for 5 years to see if they developed any complications that might be due to polycythemia vera or essential thrombocythemia.

What did the researchers find?

Of the 10 000 people studied, 1 person had known polycythemia vera, 1 had known essential thrombocythemia, 88 had high red blood cell counts, and 99 had high platelet counts. Of those with high red blood cell counts, the second test confirmed high red blood cell counts in 35 of the 88 and high platelet counts in 8 of the 99 with abnormal first test results. Additional evaluation of these people showed that 2 had polycythemia vera and 3 had essential thrombocythemia. Over the 5 years of follow-up, no patient had a complication. This study suggests that polycythemia vera and essential thrombocythemia occur in about 300 and 400 of every million people, respectively.

What were the limitations of the study?

This study examined only people in a single geographic area and included only people age 18 to 65 years. The frequency of polycythemia vera and essential thrombocythemia may be different in other populations. Also, while no complications were observed, the people were followed for only 5 years.

What are the implications of the study?

Polycythemia vera and essential thrombocythemia may be more common among otherwise healthy persons age 18 to 65 years than previously thought, but complications are uncommon.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Advertisement

Related Content

Customize your page view by dragging & repositioning the boxes below.

Topic Collections
PubMed Articles
Comprehensive review of JAK inhibitors in myeloproliferative neoplasms.
Therapeutic advances in hematology Issue date: 2013 Feb
The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression - an overlapping myeloproliferative disorder or two distinct diseases? - case report.
Journal of medicine and life Issue date: 2013 Mar 15

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)